| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
den Heijer JM, Kruithof AC, Moerland M, Walker M, Dudgeon L, Justman C, Solomini I, Splitalny L, Leymarie N, Khatri K, Cullen VC, Hilt DC, Groeneveld GJ, Lansbury P. A Phase 1B Trial in GBA1-Associated Parkinson's Disease of BIA-28-6156, a Glucocerebrosidase Activator. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37195859 DOI: 10.1002/mds.29346 |
0.01 |
|
| 2023 |
den Heijer JM, Cullen VC, Pereira DR, Yavuz Y, de Kam ML, Grievink HW, Moerland M, Leymarie N, Khatri K, Sollomoni I, Spitalny L, Dungeon L, Hilt DC, Justman C, Lansbury P, et al. A Biomarker Study in Patients with GBA1-Parkinson's Disease and Healthy Controls. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 36916660 DOI: 10.1002/mds.29360 |
0.01 |
|
| 2022 |
Cuddy LK, Alia AO, Salvo MA, Chandra S, Grammatopoulos TN, Justman CJ, Lansbury PT, Mazzulli JR, Vassar R. Farnesyltransferase inhibitor LNK-754 attenuates axonal dystrophy and reduces amyloid pathology in mice. Molecular Neurodegeneration. 17: 54. PMID 35987691 DOI: 10.1186/s13024-022-00561-9 |
0.01 |
|
| 2021 |
den Heijer JM, Kruithof AC, van Amerongen G, de Kam ML, Thijssen E, Grievink HW, Moerland M, Walker M, Been K, Skerlj R, Justman C, Dudgeon L, Lansbury P, Cullen VC, Hilt DC, et al. A randomized single and multiple ascending dose study in healthy volunteers of LTI-291, a centrally penetrant glucocerebrosidase activator. British Journal of Clinical Pharmacology. PMID 33576113 DOI: 10.1111/bcp.14772 |
0.01 |
|
| 2019 |
Cuddy LK, Wani WY, Morella ML, Pitcairn C, Tsutsumi K, Fredriksen K, Justman CJ, Grammatopoulos TN, Belur NR, Zunke F, Subramanian A, Affaneh A, Lansbury PT, Mazzulli JR. Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein. Neuron. PMID 31648898 DOI: 10.1016/J.Neuron.2019.09.001 |
0.01 |
|
| 2017 |
Collier TJ, Srivastava KR, Justman C, Grammatopoulous T, Hutter-Paier B, Prokesch M, Havas D, Rochet JC, Liu F, Jock K, de Oliveira P, Stirtz GL, Dettmer U, Sortwell CE, Feany MB, et al. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form. Neurobiology of Disease. PMID 28711409 DOI: 10.1016/J.Nbd.2017.07.007 |
0.01 |
|
| 1996 |
Deardorff DR, Savin KA, Justman CJ, Karanjawala ZE, Sheppeck II JE, Hager DC, Aydin N. Conversion of Allylic Alcohols into Allylic Nitromethyl Compounds via a Palladium-Catalyzed Solvolysis: An Enantioselective Synthesis of an Advanced Carbocyclic Nucleoside Precursor(1). The Journal of Organic Chemistry. 61: 3616-3622. PMID 11667207 DOI: 10.1021/Jo951510S |
0.01 |
|
| Hide low-probability matches. |